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Glioblastoma multiforme (GBM) is the most frequently occurring brain malignancy. Due
to its poor prognosis with currently available treatments, there is a pressing need
for easily accessible, non-invasive techniques to help inform pre-treatment planning,
patient counseling, and improve outcomes. In this study we determined the feasibility
of resting-state functional connectivity (rsFC) to classify GBM patients into short-
term and long-term survival groups with respect to reported median survival (14.6
months). We used a support vector machine with rsFC between regions of interest
as predictive features. We employed a novel hybrid feature selection method whereby
features were first filtered using correlations between rsFC and OS, and then using the
established method of recursive feature elimination (RFE) to select the optimal feature
subset. Leave-one-subject-out cross-validation evaluated the performance of models.
Classification between short- and long-term survival accuracy was 71.9%. Sensitivity
and specificity were 77.1 and 65.5%, respectively. The area under the receiver operating
characteristic curve was 0.752 (95% CI, 0.62–0.88). These findings suggest that highly
specific features of rsFC may predict GBM survival. Taken together, the findings of this
study support that resting-state fMRI and machine learning analytics could enable a
radiomic biomarker for GBM, augmenting care and planning for individual patients.
Keywords: brain tumor, resting state functional connectivity, biomarker, overall survival, short and long-term
survival, classification, support vector machine
INTRODUCTION
Glioblastoma multiforme (GBM) is the most frequently occurring brain malignancy. The median
survival time is very poor, ranging from 12 to 14.6 months following diagnosis and after receiving
the therapeutic standard of care (1, 2). Only 3–5% of GBM patients survive longer than 3 years
after diagnosis (3). Facing such abbreviated lifespans, decisions of care balancing aggressiveness of
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treatment with impacts on quality of life, are critical to patients.
As a result, the identification of novel prognostic biomarkers may
have substantial and meaningful impact for individual patients
making decisions for their terminal care.
Currently, a tissue diagnosis is required for definitive
histopathologic confirmation and optimizing the next steps
of care. Factors currently known to be associated with
survival include age, Karnofsky performance status (KPS) (4),
O6-methylguanine–DNA methyltransferase promoter (MGMT)
hypermethylation (5), and mutations in isocitrate dehydrogenase
(IDH) 1 or 2 (6, 7). Furthermore, gene expression–based
molecular classification of GBM (8), epidermal growth factor
receptor amplification (EGFR) (9) and CpG island methylator
phenotype status have emerged as additional potential predictors
of treatment response and outcome (10). Although such
molecular information has improved the clinical assessment of
GBM and has been used to better inform clinical trials (5–
8, 10, 11), there remains unmet clinical need for accessible, non-
invasively acquired biomarkers that predict clinical prognosis
and response to therapy for individual patients prior to surgical
intervention and biopsy.
There are numerous efforts in imaging radiomics to map
image features to molecular data. As an example, investigators
have correlated quantitative computed tomography (CT) image
features to gene expression data of non-small cell lung cancer
to predict survival (12, 13). Similarly in GBM, prior work has
demonstrated associations between imaging and gene expression
(14). These insights have been used to predict response to
treatment of gliomas (9). Further, by forming clustering patterns
on structural MRI across patients, these patterns can be used
to identify GBM phenotypic subtypes (15). In addition to the
molecular and genetic features, the synaptic input of neurons on
glioblastoma cells has been shown to be a powerful influence of
promoting tumor growth (16). Currently, there is no imaging
biomarker of this synaptic interaction.
Increasingly, it has become clear that brain networks and their
alterations associated with GBM have an impact on survival.
Stoecklein et al. demonstrated that resting-state functional
connectivity (rsFC) measured by MRI is affected by gliomas
throughout the whole brain and this information indicated
individual glioma disease burden (17). Daniel et al. took these
findings further to show that functionally connected voxels can
be routinely found within glioblastoma tumors and that intra-
tumor connectivity strength is a prognostic marker for overall
survival (18). What is currently lacking is a methodology that
leverages these group-level scientific findings and provides an
actionable imaging biomarker that can inform and guide clinical
care of individual patients.
In this study, we examined whether rsFC between pre-
defined regions of interest (ROIs) can enable machine learning
algorithms to predict overall survival (OS) for individual patients.
For this, we used resting-state functional MRI with blood oxygen
level-dependent (BOLD) signals acquired in 64 de novo GBM
patients prior to standard of care treatment with surgery and
chemoradiation. Retrospectively, patients’ clinical course and
rsFC between ROIs trained a support vector machine (SVM) to
predict OS. In this work we provide evidence that the alterations
of functional organization of the brain can provide insights into
predicting a GBM patient’s oncologic course.
MATERIALS AND METHODS
Participants
A total of 64 patients with a pathologic diagnosis of GBM
were included in this study. Patients were recruited from the
neurosurgery brain tumor service, initially as part of a National
Institutes of Health (NIH) funded tumor database project (NIH
5R01NS066905). Inclusion criteria stipulated that each patient
was newly diagnosed with a brain tumor, that they underwent
surgical treatment of the tumor, that the pathology was GBM,
and that there was a pre-surgical indication for structural MRI
and resting-state functional MRI as determined by the treating
neurosurgeon. Exclusion criteria were age <18 years and prior
surgery for a brain tumor. All patients provided written informed
consent and the study was approved by the Institutional Review
Board of the Washington University in St. Louis.
Group Construction and Patient Demographics
GBM patients were classified into two groups with respect to
the median duration of OS: 14.6 months (1). Patients surviving
<14.6 months were grouped as short-term survival (STS)
while those surviving 14.6 months or longer were grouped as
long-term survival (LTS). Demographic, clinical and molecular
characteristics of STS and LTS groups are summarized inTable 1.
MRI Acquisition
Imaging was done on Siemens Trio or Skyra MRI scanners
operating at 3T. Patients were scanned using a standard
presurgical tumor protocol. Structural imaging included T1-
weighted magnetization prepared rapid acquisition gradient
echo (MPRAGE) and T2-weighted fast spin-echo. Resting-
state functional MRI was acquired using echo-planar imaging
sequences (voxel size = 3mm cubic; echo time = 27ms;
repetition time = 2.2–2.9 s; field of view = 256mm; flip angle =
90◦) for a total of 320 frames.
Resting-State Functional Connectivity
(rsFC) Pre-processing
We used standard pre-processing approaches previously
described (19, 20). Denoising methods included slice timing
corrections which removed systematic slice intensity differences
due to interleaved acquisition, and head motion corrections
within and across runs. Atlas transformations were achieved
by the composition of affine transforms connecting functional
imaging volumes with T2-weighted and T1-weighted structural
images. Thereby, we registered volumetric BOLD time series
to an isotropic 3mm atlas space. Additional preprocessing
included spatial smoothing (isotropic 6mm full-width half-
maximum Gaussian blur), removal of linear temporal trends
from voxels in each scanning run, and temporal low-pass
filtering to retain frequencies <0.1Hz. Spurious variances were
reduced by regression of nuisance waveforms derived from head
motion correction and time series sampled from regions of
white matter and cerebrospinal fluid. The whole-brain (global)
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TABLE 1 | Patients’ demographic, clinical, and molecular characteristics of
patient population by group.
Summary of characteristics
Short term
survival (n = 35)
Long term
survival (n = 29)
P-value






Male 21 (60.0%) 24 (82.8%) 0.058
Female 14 (40.0%) 5 (17.2%)
CE volume (cm3) 37.6 ± 28.7 22.9 ± 28.7 0.004
FLAIR volume (cm3 ) 109.4 ± 67.6 83.4 ± 76.5 0.074
KPS, n (%)
>70% 6 (21.4%) 13 (52.0%) 0.025
Missing 7 4
Extent of resection
Gross-total 11 (31.4%) 10 (34.5%)
Subtotal 13 (37.1%) 14 (48.3%)
Laser 7 (20.0%) 1 (3.5%)
Biopsy 4 (11.4%) 4 (13.8%)
MGMT status
Methylated 12 (37.5%) 13 (52.0%) 0.297




Wild type 34 29
Missing 1 0
EGFR amplification
Positive 6 (30.0%) 12 (63.2%) 0.056
Negative 14 (70.0%) 7 (36.8%)
Missing 15 10
Overall survival in days 242.1 ± 118.0 840.9 ± 372.6 <0.00001
STS, short-term survival (<14.6 months); LTS, long-term survival (≥14.6 months); CE,
contrast enhancement; FLAIR, fluid-attenuated inversion recovery; KPS, Karnofsky
performance status; MGMT, methylguanine methyltransferase; IDH, isocitrate
dehydrogenase; EGFR, epidermal growth factor receptor.
signal was removed as a nuisance regressor. Frame censoring
was performed to minimize the impact of head motion on FC
computations. Thus, for each volumetric frame, if the root-
mean-square of voxel intensities within brain regions changed
significantly compared to the previous frame, the frame was
censored. Significant changes were defined as those that exceeded
0.5% of root-mean-square voxel intensities.
Resting-State Functional Connectivity
(rsFC) Analysis
The BOLD time series for pre-defined volumetric ROIs were
obtained by averaging the voxel time series within each ROI.
The rsFC between any pair of ROIs was then defined as
Pearson’s product moment correlation coefficient between ROI-
specified time series. We used the set of 300 ROIs from
the study by Seitzman et al. [see (21), for detail]. Briefly
summarized, this set of 300 spherical ROIs comprise 264
previously described ROIs (22) with the addition of subcortical
and cerebellar ROIs. Thus, the ROI set comprised 239 cortical,
34 subcortical, and 27 cerebellar ROIs. The cortical ROIs
belong to one of 13 resting-state networks (RSNs): the cingulo-
opercular network (CO), frontoparietal network (FPN), dorsal
attention network (DAN), ventral attention network (VAN),
salience (SAL) network, somatomotor dorsal (SMD) network,
somatomotor lateral (SML) network, visual (VIS) network,
auditory (AUD) network, medial temporal lobe (MTL) network,
reward (REW) network, parietomedial (PMe) network, the
default-mode network (DMN), and cerebellum regions (all
cerebellum ROIs). Finally, we identified a collection of twelve
ROIs which overlapped with atlas regions for white matter
and tentorium, excluding their assignment to any of the 13-
resting state functional network. This was consistent with
methodological precedence for avoiding confounding of resting-
state inferences by ROIs encompassing non-graymatter (22), also
see Supplementary Material. Thus, for each subject, a 288× 288
functional connectivity (FC) matrix was computed.
Classification Using Machine Learning
We used the Caret package available within RStudio to
implement our machine learning classifier [(23), rstudio.com].
We used a support vector machine (SVM) with linear kernel
because of its favorable reported predictive performance in
medical knowledge discovery with small amounts of training
data (24). Because of the limited number of patients in
the present study and our aim to minimizing bias in the
estimate of classification accuracy, we used the leave-one-out
(LOO) cross-validation method. An overview is illustrated in
Figure 1. Our use of LOO cross-validation adhered to standard
prescriptions for cross-validation implemented in the Caret
package. For pedagogical overviews of cross-validation and
SVM we recommend the cross-disciplinary textbook by Hastie
et al. (25).
This analysis included 64 patients, thus 64-folds of LOO cross-
validations. For example, for the first cross-validation fold, all
data from one patient were withheld and data from the 63
remaining patients were used for feature selection, training the
SVM and tuning hyperparameters. Then, the fold-1 model was
tested against the held-out data. In the next cross-validation fold,
all data from a different patient were withheld and data from the
63 remaining patients were used for feature selection, retraining
the SVM and retuning hyperparameters. Then, the fold-2 model
was tested against the held-out data and so on until we predicted
(tested) all 64-subjects by running such 64-folds.
The Pearson product moment correlation of 288 ROIs
specified in section Resting-State Functional Connectivity (rsFC)
Analysis is represented by a correlation matrix of size 288 × 288
(Figure 1, step 1). Diagonal matrix elements are exactly unity
and non-informative while upper triangular matrix elements are
symmetric to lower triangular matrix elements. Consequently,
we count the informative correlations over ROIs to be 41,328,





. We defined the
Fisher z-transformation of this set of informative correlations to
be the original features for rsFC. Since the number of original
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FIGURE 1 | Overview of machine learning. Step 1: the rsFC matrix of size 288 × 288 was computed for each patient. The features were rsFC between pairs of ROIs
(for example, the correlation between ROI X and ROI Y represented by dots in step 1). Step 2: feature selection was performed in two steps using only the lower
triangular rsFC matrix to exclude self and symmetric connections. First (i), features with correlation with patients’ days of overall survival OS (p < 0.05, uncorrected)
were selected for heuristic filtering. Then (ii), recursive feature elimination (RFE) was used to select the best predicting feature subset. Step 3: hyperparameter
optimization and final SVM model training was performed. Step 4: the trained model from the cross-validation fold was tested against the single held-out subject.
Steps 1–4 were repeated for each fold of leave-one-out cross-validation. Step 5: following all cross-validation folds, accuracy, AUC, sensitivity, and specificity for the
full sample set were computed.
FIGURE 2 | Heatmaps showing the distribution of tumor density, defined by contrast-enhanced (CE) T1w boundaries, in the full sample of 64 patients.
features, 41,328, is much higher than the number of patients, we
used feature selection to avoid overfitting our SVM.
Feature selection was performed in two steps (26, 27)
(Figure 1, step 2). First, using all patient training data (except the
withheld subject’s data), we computed the correlation of original
features for rsFC to OS expressed as continuous time of survival.
We discarded features with p-value >0.05 (uncorrected) for
heuristic filtering. The p-value for correlations was not used for
significance testing of any kind. Second, we used recursive feature
elimination (RFE) (28) which also ranks features according
to their predictive ability. However, features tend to also be
correlated with one another and so the multivariate discriminant
classifier retains high dimensionality. RFE repeatedly, and
recursively, evaluates the rank of features for predictively ability,
eliminating the worst performing features. Within the RFE
framework, we used 4-fold internal cross-validation (not to be
confused with external LOO cross-validation) with ten iterations
to obtain ranked selected features for rsFC. Internal cross-
validations and iterations are necessary for RFE to correctly
eliminate large numbers of features. Using heuristic p-value
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filtering and RFE, we reduced rsFC features from 41,328 to the
best performing features subset. Our strategy submitted these
best performing features to SVM.
As with other machine learning algorithms, SVM may
perform poorly until hyperparameters are tuned for the problem
domain. The caret package enabled tuning SVM scaling and
model complexity cost using grid search (Figure 1, step3). Thus,
the main parameters, the cost in case of linear SVM, was
estimated by using the grid-search algorithm at the scale of c =
1:10. We used 4-fold cross-validation for hyperparameter tuning
following feature extraction, feature selection (p-value filtration
and RFE), and in model training. Following training on 63
patients of the training set from LOO, we tested classification
performance on the single held-out patient of the test set from
LOO (Figure 1, step 4). Upon completion of 64 LOO folds, we
ascertained the performance of the final classifier, computing
accuracy, specificity and sensitivity values using the standard
confusion matrix (see Supplementary Material for detail). To
evaluate overall model performance, we also performed Receiver-
operating Characteristic (ROC) curve analysis.
RESULTS
A total of 64 patients diagnosed with de novo GBM were
partitioned into two groups, STS and LTS, based on overall
survival (OS). The summary of patient’s clinical, molecular,
and genetic characteristic of present sample were also reported
in Table 1. To test the significance of differences in summary
characteristics between two groups, we performed the Mann-
Whitney U-test (for the continuous variables; age, CE and
FLAIR volume, KPS) and Fisher’s exact test (for the categorical
variables: Sex, MGMT status, IDH mutation, EGFR) and p-
value of resultant test were also reported (Table 1). Furthermore,
the heterogeneity of GBM location, size, and morphology is
illustrated in Figure 2. These heatmaps represent the distribution
of tumor density in the entire patient cohort as defined by
contrast-enhanced (CE) T1w boundaries segmented by using the
software application ITK-SNAP (29). The distribution shows no
systematic asymmetry or focality that could significantly bias
the results.
Correlation Between Resting-State
Functional Connectivity and Overall
Survival (OS)
Figure 3 illustrates how each element of the matrix of canonical
functional connectivities correlates with OS. That is, for each
element of functional connectivity between ROIs, the vector of
measured functional connectivities for 64 patients was correlated
with the vector of days of OS for the patients. Please note that the
surface color in the Figure 3 represents the correlation between
OS and ROI-to-ROI rsFC. Figure 3 demonstrates that there are
no obvious patterns by which OS may be inferred directly from
rsFC. Matrix elements in red denoting positive correlations with
OS intersperse with matrix elements in blue denoting negative
correlations withOS. This absence of semantic patternsmotivates
techniques of feature reduction and inference by machine
FIGURE 3 | Correlation between rsFC (Fisher’s z transformed pairwise ROI
correlation) and OS. The horizontal and vertical axis of the plot is the ROI
number sorted by the resting-state network. The surface color represents the
correlation between OS and ROI-to-ROI rsFC. Correlation strength between
ROI pair and OS is represented by colorbar. AUD, auditory; CO,
cingulo-opercular; DMN, default-mode network; DAN, dorsal attention
network; FPN, frontoparietal network; MTL, medial temporal lobe; PMe,
parietomedial network; REW, reward network; SAL, salience network; SMD,
somatomotor dorsal network; SML, somatomotor lateral network; VAN, ventral
attention network; VIS, visual network; and Cereb, cerebellum regions (all).
learning. The strategy of heuristic filtering using uncorrected p-
values <0.05 pruned 41,328 unique matrix elements to ∼1,550
selected matrix elements (the number may change slightly from
the fold to fold of LOO cross-validation). The strategy of
wrapping using RFE pruned selected matrix elements to just 60
using a principled feature reduction technique (28). The 60 final
matrix elements were given to SVM for classification (also see
Supplementary Material for details)
Machine Learning Classification of
Short-Term Survival (STS) and Long-Term
Survival (LTS) GBM Patients
The performance of our classification schemes in predicting
short vs. long term survival are presented in Table 2. Briefly;
within-patient classification accuracy was 71.88%. Similarly, the
sensitivity and specificity were 77.14 and 65.52%, respectively.
The area under the curve (AUC) value was 0.752 (95% CI, 0.62–
0.88). The receiver operating characteristic (ROC) curves for
stratifying patients is shown in Figure 4.
The Most Predictive Features
In order to assess the predictive contribution of each features,
we sorted the top 60 contributing features as follows. During
model training, feature selection was performed on the training
set within each LOO fold, producing variations of selected
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TABLE 2 | Classification performance summary of SVM classifier.
SVM (LOO) Accuracy Sensitivity Specificity AUC C
STS vs. LTS 71.88% 77.14% 65.52% 0.752 1
Regarding C, although we used the grid-search algorithm at the scale of c = 1:10 to optimize C, all selected C were 1.
FIGURE 4 | ROC analysis for the STS vs. LTS classification.
features across cross-validation folds. We stored the 60 top-
ranking features from SVM-RFE from each LOO fold. We then
sorted features according to their frequency of occurrence in all
64 LOO folds. Figure 5 illustrates, as network adjacency maps,
the RSN distribution of the selected features using vertices for
ROIs (node) and edges for correlations of selected features with
OS. Of the top 60 features, 27 were reproducibly found in all 64
LOO folds, invariant to tumor and physiologic variability across
patients [for completeness, anatomical distribution of these top
60 and 27 shared features (separately) were also plotted, see
Supplementary Figures 1, 2, respectively].
DISCUSSION
Anatomic and functional imaging currently is routinely utilized
prior to and during the resection of brain tumors. This
technology has been shown to improve the extent of tumor
resection (30), and as a result, improve survival statistics (31).
That said, it is not routine prior to resections to make use of
imaging that reflect the functional organization of the brain
and its interaction with the tumor to provide insight into long-
term prognosis. Beyond, guiding the specific surgery per se, deep
insight into the aggressiveness of the tumor informs fundamental
decision making about the total course of care. Historically, task-
based fMRI has been employed as a means of pre-operatively
localizing function (32). During the past decade, it has been
shown that the representation of multiple motor, sensory, and
cognitive functions can be mapped by analysis of intrinsic brain
activity, acquisition of which requires only that the patient hold
still during fMRI (33–35). Thus, resting-state fMRI provides a
much more complete functional map of the brain than does task-
based fMRI; moreover, rs-fMRI is more reliable and much more
time-efficient. Finally, the robustness of this mapping modality
enables the identification of functional tissue both within a
tumor (providing insight into glial-neuronal interactions) and
throughout the brain (providing measures of global functional
distortions (17, 18, 36–38), What has remained a challenge has
been dealing with the complexity and magnitude of the resting-
state fMRI data to provide reliable and actionable insights that
can enhance clinical care.
Machine learning approaches creates the opportunity to
organize large amounts of data to support more generalized
and actionable interpretations. In the context of prognostic
radiomics for GBM there are several considerations that merit
attention. First, in the supervised context, as done in this work,
predictions were formulated by direct comparisons of abundant
functional data and outcome measurements. Recursive feature
elimination (RFE) with support vector machines (SVM) were
chosen because they outperformed many popular classification
algorithms in a survey of neuroimaging studies of brain
disorders: simple thresholding, centroid methods, minimum
distance, discriminant function analysis, Gaussian process,
spectral clustering, fused lasso, random forests, perceptrons,
stacked auto-encoder neural networks, SVM without RFE (39,
40). Second, appropriately selecting features, which determine
the dimensionality of a machine learning model, is critical for
SVM in the face of limited outcome data, such as the OS
of GBM patients. Valid selection of features can help increase
prediction accuracies and can also help interpretability. This
work made use of a heuristic filtering method that calculated
correlations and used uncorrected p-values to prune features.
RFE then served as a wrapper method to further prune features
that were most appropriate for the problem of predicting OS for
GBM patients. Third, a linear SVM provided classification.While
our feature selection choices provided limited interpretability
of feature subsets (network topographies and patterns in
neuroanatomy were not evident), feature selection did improve
clinically relevant prediction accuracies. Specifically, this work
demonstrated that patients with GBM can be partitioned
into short term and long-term survival groups using features
extracted from resting-state fMRI (Table 2 and Figure 4). These
findings complement previous work demonstrating the potential
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FIGURE 5 | The top-60 frequently selected features are shown in circle. (A) Red connection (line) indicates the positive correlation of connections (i.e., rsFC) with OS
and that of negatively correlated connections are in blue (B). The color of the outer sphere represents the resting-state network (RSN) that the ROIs belongs to. AUD,
auditory; CO, cingulo-opercular network; DMN, default-mode network; FPN, frontoparietal network; MTL, medial temporal lobe; REW, reward network; SAL, salience
network; SMD, somatomotor dorsal network; SML, somatomotor lateral network; VAN, ventral attention network; VIS, visual network; and Cereb, cerebellum regions
(all).
of rsFC as a biomarker of OS in GBM patients (18). Notably, this
work demonstrates predictions of OS for individual patients.
While the prediction of OS is clinically important a caution
is warranted in interpreting the features used to make those
predictions because of the nature of support vectors in
determining decision hypersurfaces in high-dimensional data.
The 60 most frequently selected features are plotted in Figure 5
(anatomical distribution of these features is also plotted, see
Supplementary Figure 1). Unlike other methods, such as linear
discriminant analysis in which features are ascribed shared
covariances that occupy the space of dominant features, our
use of RFE-SVM selects features which serve as kernel bases
optimally separating features which are most ambiguous along
the decision boundary. Consequently, while having optimal
benefits for generating decision hypersurfaces, our selected
features for rsFC in fact visualize anatomy and network
adjacencies that are most ambiguous for predicting OS. The
difficulty of interpreting features selected by machine learning
algorithms is a common problem of neuroimaging research.
Many features contribute to the classification of OS because of
the complexity of factors that determine OS. Broadly distributed
features have been found in many previous investigations of rsFC
in GBM patients (41–43).
FC studies have markedly advanced our knowledge of human
brain function and its organization. Thus, rsFC has been used to
characterize individuals’ functional brain organization in patients
with a broad range of neurosurgical diseases including GBM.
Relatively recently, there were reports of significant alteration
of brain functional connectivity in GBM (42, 43). We, for the
first time, directly tested the relationship of such changes with
OS in GBM patients (Figure 3). We emphasize the advantages of
rsFC over task-based MRI. For instance, resting-state functional
MRI can be acquired in patients that are unable to cooperate
with a task, such as cognitively impaired patients as they do
not need to perform a task (20, 44, 45). Moreover, task-based
fMRI conventionally is restricted to mapping the representation
of motor and speech function, which omits other important
functions (e.g., executive function, attention, etc.) and does not
perform a whole brain assessment. Even the waking state during
fMRI is not required as essentially the same functional maps are
obtained even if the patient is asleep or sedated (46–48). Thus,
rsFC provides information complementary to that obtained from
structural imaging of brain tumors. Notably, rsFC throughout the
brain is affected by gliomas, even in the non-lesional hemisphere
(41–43). This was one of the key motivations for this study.
To our knowledge, no previous studies have examined
correlations between rsFC and individual OS as a filtering
heuristic. While weak correlations have no role for testing
hypothesis, they can provide intermediate data for consumption
by more principled algorithms, such as RFE and SVM. These
weak correlative relationships may be interpretable in the context
that functional connectivity across networks correlates with
a patient’s cognitive function (41, 49, 50). In cases of high
grade GBM, reports describe marked decline in neurocognitive
functioning during the course of a patient’s disease (51).
Moreover, poorer performance on initial cognitive testing is
associated with shorter survival (52). Here we demonstrate that
a trained SVM predicts short and long-term survival in GBM
patients based on rsFCmeasures. Previous work in GBM patients
have shown that cognitive impairment in GBM patients can be
associated with both increases and decreases in rsFC (53, 54).
The ability of several rsFC ROI pairs to predict OS further
extends our previous report that intratumor rsFC may be
a prognostic marker for overall survival (18). This finding
aligned with previous reports that brain tumors can lead to
various cognitive deficits and are related to alterations in
local and interhemispheric rsFC across functional networks
(49, 50, 55, 56). Here we showed that particular ROI-pair
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dependent reductions and increases in rsFC are associated with
OS prediction, suggesting that connectivity alterations at specific
cortical locations play an important role in influencing outcomes.
Thus, local and global rsFC changes in GBM patients may act as
a biomarker for prognosis and disease monitoring.
LIMITATIONS
A common deficiency of neuroimaging studies is limitations
of sample size in the presence of data with high dimensional
sets of features (57). The difficulties of machine learning
methods under these restrictions include overfitting and the
inability to adequately represent the complexity of the underlying
study problem. Feature selection did not account for tumor
location, tumor staging, tumor grading, and aspects of patient
demography, such as age, sex, and ethnicity. However, inclusion
of such additional features in the classifier are likely to improve
the performance of the classifier described in this work. There
remain issues regarding reproducibility and generalizability of
results. Partial solutions include recruiting larger numbers of
patients for study and testing models with unseen data. In this
work, we used LOO on all available patient data.
CONCLUSION AND FUTURE WORK
In summary, our results demonstrate that resting-state functional
connectivity provides prognostic biomarkers for individual
patients with GBM. This work demonstrates prognostic
classification of short-term survival vs. long-term survival and
suggests how future work may attain more precise predictions
of years of survival for individual patients. Such efforts may
require extensive longitudinal data to attain clinical utility
but such precision predictions would have substantial and
meaningful impact for patients with GBM making decisions for
their terminal care.
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